Business
Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction Patch(TM)
Premier Biomedical, Halberd and Gold River Agree to Work Jointly to Develop Premier's Patented Extracorporeal Technology on COVID-19 Treatment And Proprietary Anti-Addiction Patch(TM).
About this update from Premier Biomedical Inc
[{"type":"text","content":"JACKSON CENTER, PA / ACCESSWIRE / April 8, 2020 / Premier Biomedical, Inc. (OTCPINK:BIEI), Halberd Corporation (HALB) and Gold River Productions Inc. (GRPS) announce the signing of a multi-faceted agreement for ongoing R&D into a potential treatment and cure for Covid-19 as well as development of Premier's Anti-Addiction Patch™.The Joint Venture on Covid-19 treatment starts with Dr. Mitchell Felder's patented extracorporeal therapy (US Patent 9,216,386 and US Patent 8,758,287) for the safe removal of targeted antigens from the blood and targeted organs. Dr. Felder explained, "The extracorporeal treatment is based on the process of removing the underlying basis of the disease. In the case of Covid-19, it entails removal of specific compounds which allow the virus to replicate. We believe this technology is superior to known treatments in that it may potentially eliminate mutations of the virus."Dr. Richard Goulding, Gold River's Chief Medical Officer stated, "Premier's multi-faceted extracorporeal technology can be used to remove the disease-causing antigens and to prevent the "cytokine storm" associated with the disease in severely ill patients."Dr. Felder continued, "With our partners, including a leading university partner, we are now positioned to develop potential cures and mitigation for Covid-19 as well as to alleviate the global drug epidemic for our country and the world. The joint venture includes financial commitments for funding, which if obtained, along with the continued research with our university partner is likely to develop the technology disclosed in our provisional patent application entitled ‘Method for Treating and Curing COVID-19 Infection'. We seek to further develop and establish proof of concept with regard to these promising tools in this worldwide battle. This positions us to facilitate defenses against the growing COVID-19 menace as well as against other viral attacks."See YouTube video, https://youtu.be/BGdZqHH6oew , concerning Dr. Felder's discussion of the scientific basis underlying Premier's extracorporeal treatment process for fighting cancer and other diseases."With COVID-19 spreading at an alarming rate, we have accelerated our efforts to develop effective tools to combat not just COVID-19 but other viruse...